VaxigripTetra Suspension zur injektion in einer fertigspritze

Negara: Swiss

Bahasa: Jerman

Sumber: Swissmedic (Swiss Agency for Therapeutic Products)

Bahan aktif:

haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022), haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/9/2021 (H3N2)-like: reassortant virus IVR-228 derived from A/Darwin/9/2021), haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: B/Michigan/01/2021, wilde type (Victoria lineage))

Tersedia dari:

Sanofi-Aventis (Suisse) SA

Kode ATC:

J07BB02

INN (Nama Internasional):

haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022), haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/9/2021 (H3N2)-like: reassortant virus IVR-228 derived from A/Darwin/9/2021), haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: B/Michigan/01/2021, wilde type (Victoria lineage))

Bentuk farmasi:

Suspension zur injektion in einer fertigspritze

Komposisi:

haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/9/2021 (H3N2)-like: reassortant virus IVR-228 derived from A/Darwin/9/2021) 15 µg, haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: B/Michigan/01/2021, wilde type (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013-like: B/Phuket/3073/2013, wilde type (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum.

Kelas:

B

Kelompok Terapi:

Impfstoffe

Area terapi:

Aktive immunisierung gegen influenza, ab dem 6. monat

Status otorisasi:

zugelassen

Tanggal Otorisasi:

2018-12-06